Kimia Biosciences Limited (BOM:530313)

India flag India · Delayed Price · Currency is INR
25.36
-3.10 (-10.89%)
At close: Mar 27, 2026
Market Cap1.20B -49.0%
Revenue (ttm)1.26B +13.5%
Net Income90.52M -3.9%
EPS1.91 -4.1%
Shares Out47.31M
PE Ratio13.28
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,203
Average Volume7,083
Open29.10
Previous Close28.46
Day's Range24.00 - 29.10
52-Week Range24.00 - 86.85
Beta0.69
RSI33.01
Earnings DateMay 26, 2026

About Kimia Biosciences

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its prod... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1993
Employees 250
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530313
Full Company Profile

Financial Performance

Financial Statements